Sermorelin research
What PubMed holds on Sermorelin, sorted by study design: the papers this site relies on, every clinical-trial publication PubMed tags, and the newest additions.
- PubMed records
- 366
- Trial publications
- 6334 randomized
- Reviews
- 10
- Human-subject tagged
- 213
- Animal-only
- 133
- Clinical-trial publications 63
- Reviews 10
- Animal-only studies 133
- Other (in vitro, chemistry, commentary, unindexed) 160
Studies this site relies on
Ordered by strength of design. Conclusions are quoted verbatim from each abstract as indexed by PubMed; read the full paper before relying on any of them.
-
A comparative study of growth hormone (GH) and GH-releasing hormone(1-29)-NH2 for stimulation of growth in children with GH deficiency
Chen RG, Shen YN, Yei J, et al.
No serious side-effects were seen, but three patients receiving GHRH(1-29)-NH2 reported mild irritation at the injection site. These results from the continuous infusion of GHRH(1-29)-NH2 over 6 months suggest that this treatment, or the related use of a depot preparation, is unlikely to be as effective as GH for the promotion of growth …
-
Pharmacokinetics of growth hormone-releasing hormone(1-29)-NH2 and stimulation of growth hormone secretion in healthy subjects after intravenous or intranasal administration
Wilton P, Chardet Y, Danielson K, et al.
The GH response after repeated intranasal administration of GHRH(1-29)-NH2 was sustained; there was no suppression of GH secretion during the night following a day when GHRH(1-29)-NH2 had been given three times intranasally. Based on these findings and the obvious convenience of intranasal administration compared with injections, it would …
-
Sermorelin: a better approach to management of adult-onset growth hormone insufficiency?
Walker RF
No abstract is available in PubMed for this record.
-
Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency
Prakash A, Goa KL
Sermorelin is a well tolerated analogue of GHRH which is suitable for use as a provocative test of growth hormone deficiency when given as a single intravenous 1 microg/kg bodyweight dose in conjunction with conventional tests. Limited data suggest that once daily subcutaneous sermorelin 30 microg/kg bodyweight is effective in promoting …
-
Treatment of growth-hormone deficiency with growth-hormone-releasing hormone
Ross RJ, Rodda C, Tsagarakis S, et al.
GHRH (1-29) NH2 therapy is an alternative to conventional hGH in the treatment of some GH-deficient children. Ideal dose regimens need to be established.
Clinical-trial publications in PubMed
63 records carry PubMed’s clinical-trial publication type; the 40 most recent are listed. Tagging is done by NLM indexers and occasionally includes secondary analyses.
Newest records
The most recent PubMed additions for this query at the data-edition date, regardless of design.
- Peptides in urology and sexual medicine: clinical effectiveness, dosing, indications, and safety: a narrative review Sex Med Rev · 2026 · Review
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance Sports Med · 2026 · Review
- Anterior cervical osteophyte-related dysphagia in a long-term growth hormone user: a case report Front Surg · 2026 · Case report
- A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review J Sports Med Phys Fitness · 2026 · Review
- The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration Front Endocrinol (Lausanne) · 2026 · Review
- Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry J Pharm Biomed Anal · 2026 · Primary study
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions J Am Acad Orthop Surg Glob Res Rev · 2026 · Review
- Universal peptide synthesis via solid-phase methods fused with chemputation Nat Commun · 2025 · Primary study
- Chromatographic-mass spectrometric analysis of peptidic analytes (2-10 kDa) in doping control urine samples J Mass Spectrom · 2024 · Primary study
- Cationic exchange SPE combined with triple quadrupole UHPLC-MS/MS for detection of GHRHs in urine samples Anal Biochem · 2023 · Primary study